| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| CHEKCheck-Cap Ltd. | 10.24M | 1.75 | -0.41 | -226.19% | ||||
| NDRAENDRA Life Sciences Inc. | 5.21M | 4.47 | -0.44 | -5.95% | 0.23 | |||
| INBSIntelligent Bio Solutions Inc. | 17.54M | 14.42 | -7.21 | -1.9% | -330.06% | -317.07% | 0.10 |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 1.41M | 515.58K | 351.62K | 6.17K | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | 1.52% | -0.63% | -0.32% | -0.98% | -1% | - | - | - | - | - |
| Cost of Goods Sold | 666.23K | 235.88K | 172.78K | 0 | 115.01K | 165.25K | 224.41K | 234.26K | 275.45K | 0 |
| COGS % of Revenue | 0.47% | 0.46% | 0.49% | - | - | - | - | - | - | - |
| Gross Profit | 743.83K | 279.7K | 178.84K | 6.17K | -115.01K | -165.25K | -224.41K | -234.26K | -275.45K | 0 |
| Gross Margin % | 0.53% | 0.54% | 0.51% | 1% | - | - | - | - | - | - |
| Gross Profit Growth % | 1.48% | -0.62% | -0.36% | -0.97% | -19.63% | -0.44% | -0.36% | -0.04% | -0.18% | 1% |
| Operating Expenses | 2.31M | 2.07M | 4.8M | 8.74M | 10.73M | 11.34M | 11.27M | 12.92M | 10.25M | 10.82M |
| OpEx % of Revenue | 1.64% | 4.02% | 13.66% | 1415.23% | - | - | - | - | - | - |
| Selling, General & Admin | 1.27M | 1.58M | 2.87M | 4.02M | 4.15M | 5.42M | 5.79M | 6.37M | 5.24M | 7.63M |
| SG&A % of Revenue | 0.9% | 3.06% | 8.17% | 650.34% | - | - | - | - | - | - |
| Research & Development | 1.04M | 495.38K | 1.93M | 4.72M | 6.57M | 5.92M | 5.48M | 6.55M | 5M | 3.19M |
| R&D % of Revenue | 0.74% | 0.96% | 5.49% | 764.9% | - | - | - | - | - | - |
| Other Operating Expenses | 0 | -5.82K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -1.57M | -1.79M | -4.63M | -9.02M | -10.84M | -11.5M | -11.5M | -13.16M | -10.52M | -10.82M |
| Operating Margin % | -1.11% | -3.48% | -13.16% | -1460.8% | - | - | - | - | - | - |
| Operating Income Growth % | -0.03% | -0.14% | -1.58% | -0.95% | -0.2% | -0.06% | 0% | -0.14% | 0.2% | -0.03% |
| EBITDA | -1.5M | -1.73M | -4.56M | -8.95M | -10.73M | -11.34M | -11.27M | -12.92M | -10.25M | -10.77M |
| EBITDA Margin % | -1.06% | -3.35% | -12.98% | -1449.74% | - | - | - | - | - | - |
| EBITDA Growth % | -0% | -0.15% | -1.64% | -0.96% | -0.2% | -0.06% | 0.01% | -0.15% | 0.21% | -0.05% |
| D&A (Non-Cash Add-back) | 72.22K | 64.94K | 61.48K | 68.32K | 115.01K | 165.25K | 224.41K | 234.26K | 275.45K | 46.49K |
| EBIT | -1.57M | -1.79M | -4.63M | -9.07M | -10.95M | -11.49M | -11.23M | -13.18M | -10.06M | -10.82M |
| Net Interest Income | 0 | 0 | 0 | -729.24K | -2.35M | -232.19K | 0 | -21.53K | 0 | 0 |
| Interest Income | 0 | 0 | 0 | 0 | 2.35K | 232 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 729.24K | 2.36M | 232.43K | 0 | 21.53K | 0 | 0 |
| Other Income/Expense | -710.63K | -983.61K | -750.9K | -777.25K | -2.46M | -223.58K | 267.06K | -21.53K | 460.49K | -690.8K |
| Pretax Income | -2.28M | -2.78M | -5.38M | -9.8M | -13.31M | -11.73M | -11.23M | -13.18M | -10.06M | -11.51M |
| Pretax Margin % | -1.62% | -5.38% | -15.29% | -1586.7% | - | - | - | - | - | - |
| Income Tax | 0 | 983.61K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 1% | 1% | 1% | 1% | 1% | 1% | 1% | 1% | 1% | 1% |
| Net Income | -2.28M | -2.78M | -5.38M | -9.8M | -13.31M | -11.73M | -11.23M | -13.18M | -10.06M | -11.51M |
| Net Margin % | -1.62% | -5.38% | -15.29% | -1586.7% | - | - | - | - | - | - |
| Net Income Growth % | -0.05% | -0.22% | -0.94% | -0.82% | -0.36% | 0.12% | 0.04% | -0.17% | 0.24% | -0.14% |
| Net Income (Continuing) | -2.28M | -2.78M | -5.38M | -9.8M | -13.31M | -11.73M | -11.23M | -13.18M | -10.06M | -11.51M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -11.67 | -14.21 | -27.47 | -43.49 | -41.48 | -12.47 | -5.47 | -6.84 | -5.89 | -10.25 |
| EPS Growth % | 0.84% | -0.22% | -0.93% | -0.58% | 0.05% | 0.7% | 0.56% | -0.25% | 0.14% | -0.74% |
| EPS (Basic) | -11.67 | -14.21 | -27.47 | -43.49 | -41.48 | -12.47 | -5.47 | -4.57 | -5.89 | -10.25 |
| Diluted Shares Outstanding | 195.35K | 195.35K | 195.75K | 225.24K | 375K | 959.61K | 2.05M | 1.93M | 1.71M | 1.12M |
| Basic Shares Outstanding | 195.35K | 195.35K | 195.75K | 225.24K | 375K | 959.61K | 2.05M | 1.93M | 1.71M | 1.12M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 126.62K | 195.59K | 5.88M | 6.95M | 6.54M | 8.21M | 12.09M | 8.53M | 3.03M | 3.43M |
| Cash & Short-Term Investments | 19.13K | 144.95K | 5.6M | 6.47M | 6.17M | 7.23M | 9.46M | 4.89M | 2.83M | 3.23M |
| Cash Only | 19.13K | 144.95K | 5.6M | 6.47M | 6.17M | 7.23M | 9.46M | 4.89M | 2.83M | 3.23M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 0 | 6.85K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | 7.11 | - | - | - | - | - | - | - |
| Inventory | 99K | 40.1K | 191.68K | 59.44K | 113.44K | 589.62K | 1.28M | 2.64M | 0 | 0 |
| Days Inventory Outstanding | 54.24 | 62.06 | 404.92 | - | 360.02 | 1.3K | 2.09K | 4.12K | - | - |
| Other Current Assets | 8.49K | 10.54K | 14.25K | 273.31K | 130.7K | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Assets | 360.1K | 295.17K | 241.55K | 273.23K | 641.17K | 557.24K | 780.53K | 747.46K | 3.72M | 1.02M |
| Property, Plant & Equipment | 360.1K | 295.17K | 241.55K | 273.23K | 641.17K | 551.25K | 774.54K | 741.47K | 465.87K | 647.29K |
| Fixed Asset Turnover | 3.92x | 1.75x | 1.46x | 0.02x | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 5.99K | 5.99K | 5.99K | 3.26M | 371.4K |
| Total Assets | 486.72K | 490.76K | 6.12M | 7.22M | 7.18M | 8.76M | 12.87M | 9.27M | 6.75M | 4.45M |
| Asset Turnover | 2.90x | 1.05x | 0.06x | 0.00x | - | - | - | - | - | - |
| Asset Growth % | -0.31% | 0.01% | 11.48% | 0.18% | -0.01% | 0.22% | 0.47% | -0.28% | -0.27% | -0.34% |
| Total Current Liabilities | 236.42K | 1.38M | 848.21K | 974.58K | 2.07M | 986.66K | 1.54M | 1.7M | 903.1K | 605.23K |
| Accounts Payable | 80.94K | 227.74K | 780.26K | 631.47K | 1.28M | 402.91K | 791.05K | 613.96K | 360.4K | 269.68K |
| Days Payables Outstanding | 44.35 | 352.41 | 1.65K | - | 4.06K | 889.94 | 1.29K | 956.62 | 477.57 | - |
| Short-Term Debt | 0 | 949.98K | 0 | 0 | 364.26K | 83.87K | 117.13K | 28.48K | 28.48K | 0 |
| Deferred Revenue (Current) | 0 | 206.81K | 0 | -23 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 0 | 72K | 0 | 22.51K | 235.35K | 0 | 0 | 158.93K | 148.79K | 169.72K |
| Current Ratio | 0.54x | 0.14x | 6.93x | 7.13x | 3.15x | 8.32x | 7.83x | 5.00x | 3.36x | 5.67x |
| Quick Ratio | 0.12x | 0.11x | 6.71x | 7.07x | 3.10x | 7.72x | 7.00x | 3.45x | 3.36x | 5.67x |
| Cash Conversion Cycle | - | - | -1.24K | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 0 | 0 | 0 | 0 | 342.81K | 608.99K | 546.63K | 365.92K | 192.06K | 1.29M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 337.08K | 28.48K | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 342.81K | 271.91K | 518.15K | 365.92K | 192.06K | 487.48K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 799.28K |
| Total Liabilities | 236.42K | 1.38M | 848.21K | 974.58K | 2.42M | 1.6M | 2.09M | 2.07M | 1.1M | 1.89M |
| Total Debt | 0 | 949.98K | 0 | 23 | 773.27K | 769.34K | 796.09K | 546.63K | 394.4K | 584.42K |
| Net Debt | -19.13K | 805.02K | -5.6M | -6.47M | -5.4M | -6.46M | -8.67M | -4.34M | -2.44M | -2.65M |
| Debt / Equity | - | - | - | 0.00x | 0.16x | 0.11x | 0.07x | 0.08x | 0.07x | 0.23x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | -12.37x | -4.60x | -49.49x | - | -611.04x | - | - |
| Total Equity | 250.3K | -893.77K | 5.28M | 6.25M | 4.76M | 7.17M | 10.78M | 7.2M | 5.66M | 2.56M |
| Equity Growth % | -0.59% | -4.57% | 6.9% | 0.18% | -0.24% | 0.51% | 0.5% | -0.33% | -0.21% | -0.55% |
| Book Value per Share | 1.28 | -4.58 | 26.95 | 27.74 | 12.70 | 7.47 | 5.27 | 3.73 | 3.31 | 2.28 |
| Total Shareholders' Equity | 250.3K | -893.77K | 5.28M | 6.25M | 4.76M | 7.17M | 10.78M | 7.2M | 5.66M | 2.56M |
| Common Stock | 253 | 253 | 392 | 742 | 842 | 3.4K | 212 | 317 | 1.04K | 53 |
| Retained Earnings | -9.74M | -12.52M | -17.9M | -27.69M | -45.22M | -57.34M | -68.69M | -81.87M | -91.93M | -103.44M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -208.09K | -276.15K | -337.63K | -405.95K | 43.53K | 10.79K | 13.86K | 6.07K | 5.23K | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -842.73K | -1.32M | -3.3M | -7.7M | -8.59M | -10.77M | -11.12M | -12.77M | -9.55M | -7.4M |
| Operating CF Margin % | -0.6% | -2.55% | -9.39% | -1247.57% | - | - | - | - | - | - |
| Operating CF Growth % | 0.4% | -0.56% | -1.51% | -1.33% | -0.12% | -0.25% | -0.03% | -0.15% | 0.25% | 0.22% |
| Net Income | -2.28M | -2.78M | -5.38M | -9.8M | -13.31M | -11.73M | -11.23M | -13.18M | -10.06M | -11.51M |
| Depreciation & Amortization | 72.22K | 64.94K | 61.48K | 68.32K | 115.01K | 165.25K | 224.41K | 234.26K | 275.45K | 206.17K |
| Stock-Based Compensation | 309.84K | 230.33K | 1K | 1.37K | 1.4K | 2.1M | 1.44M | 1.2M | 996.43K | 571.92K |
| Deferred Taxes | 25K | 0 | 0 | 0 | -1.4K | -2.1M | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 686.34K | 909.5K | 1.72M | 2.38M | 4M | 2.33M | -298.73K | 1.39K | 162.91K | 3.2M |
| Working Capital Changes | 343.07K | 254.98K | 298.66K | -359.08K | 597.83K | -1.55M | -1.26M | -1.03M | -923.32K | 134.08K |
| Change in Receivables | 0 | 0 | -6.85K | 6.85K | -760.14K | 834.99K | -491.1K | 0 | 0 | 0 |
| Change in Inventory | 139.98K | 58.9K | -151.57K | -155.31K | -54K | -476.18K | -694.96K | -1.36M | 138.04K | 235.73K |
| Change in Payables | 202.59K | 198.13K | 528.29K | -6.19M | 760.14K | -834.99K | 491.1K | 111.58K | -822.26K | -198.87K |
| Cash from Investing | -133.81K | 0 | -7.86K | -100K | -43.59K | -51.33K | -45K | -202.58K | -24.72K | -12.8K |
| Capital Expenditures | -133.81K | 0 | -7.86K | -100K | -43.59K | -51.33K | -45K | -202.58K | -33.88K | -16K |
| CapEx % of Revenue | 0.09% | - | 0.02% | 16.2% | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - | - | - | - | - |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9.16K | 3.2K |
| Cash from Financing | 839.22K | 1.44M | 8.77M | 8.67M | 8.34M | 11.88M | 13.4M | 8.4M | 7.52M | 7.81M |
| Debt Issued (Net) | - | - | - | - | - | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - | - | - | - | - | - |
| Dividends Paid | 0 | 0 | 0 | 0 | -4.22M | -395.55K | -121.07K | -7.79K | -840 | -5.23K |
| Share Repurchases | - | - | - | - | - | - | - | - | - | - |
| Other Financing | 0 | 5K | 8.59M | 7.74M | 10.06M | 5.15M | 2.91M | 0 | 1.04M | 1 |
| Net Change in Cash | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | -976.54K | -1.32M | -3.31M | -7.8M | -8.63M | -10.82M | -11.17M | -12.97M | -9.58M | -7.42M |
| FCF Margin % | -0.69% | -2.55% | -9.41% | -1263.76% | - | - | - | - | - | - |
| FCF Growth % | 0.42% | -0.35% | -1.51% | -1.36% | -0.11% | -0.25% | -0.03% | -0.16% | 0.26% | 0.23% |
| FCF per Share | -5.00 | -6.73 | -16.90 | -34.64 | -23.02 | -11.28 | -5.46 | -6.72 | -5.61 | -6.61 |
| FCF Conversion (FCF/Net Income) | 0.37x | 0.47x | 0.61x | 0.79x | 0.65x | 0.92x | 0.99x | 0.97x | 0.95x | 0.64x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Metric | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -532.75% | - | -245.43% | -170.02% | -241.73% | -196.57% | -125.11% | -146.53% | -156.42% | -280.02% |
| Return on Invested Capital (ROIC) | -345.98% | -1887.02% | - | - | - | -24273.5% | -609.42% | -396.24% | -259.49% | -517.6% |
| Gross Margin | 52.75% | 54.25% | 50.86% | 100% | - | - | - | - | - | - |
| Net Margin | -161.64% | -538.3% | -1529.19% | -158669.6% | - | - | - | - | - | - |
| Debt / Equity | - | - | - | 0.00x | 0.16x | 0.11x | 0.07x | 0.08x | 0.07x | 0.23x |
| Interest Coverage | - | - | - | -12.37x | -4.60x | -49.49x | - | -611.04x | - | - |
| FCF Conversion | 0.37x | 0.47x | 0.61x | 0.79x | 0.65x | 0.92x | 0.99x | 0.97x | 0.95x | 0.64x |
| Revenue Growth | 152.09% | -63.44% | -31.8% | -98.24% | -100% | - | - | - | - | - |
ENDRA Life Sciences Inc. (NDRA) grew revenue by 0.0% over the past year. Growth has been modest.
ENDRA Life Sciences Inc. (NDRA) reported a net loss of $8.8M for fiscal year 2024.
Yes, ENDRA Life Sciences Inc. (NDRA) pays a dividend with a yield of 0.10%. This makes it attractive for income-focused investors.
ENDRA Life Sciences Inc. (NDRA) has a return on equity (ROE) of -280.0%. Negative ROE indicates the company is unprofitable.
ENDRA Life Sciences Inc. (NDRA) had negative free cash flow of $5.6M in fiscal year 2024, likely due to heavy capital investments.